| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $21,090,042 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U01DK135007 | Identifying Metabolic and Psychosocial Antecedents and Characteristics of youth-onset Type 2 diabetes (IMPACT DM) | 000 | 2 | NIH | 3/5/2024 | $552,800 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 00 | 28 | HRSA | 11/16/2023 | $212,514 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA233193 | A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials | 000 | 6 | NIH | 2/19/2024 | $1,744,559 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK122028 | Aryl hydrocarbon receptor-mediated differential gene regulation - Mechanism of stanniocalcin 2 mediated protection against NAFLD | 000 | 7 | NIH | 1/12/2024 | $315,375 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H3306689 | EMSC Partnership Grants | 00 | 19 | HRSA | 3/21/2024 | $83,352 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY028608 | Caveolae-Based Mechanosensors for Conventional Outflow Regulation | 001 | 5 | NIH | 2/14/2024 | $615,972 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA225439 | Tribally Engaged Approaches to Lung Screening (TEALS) | 001 | 5 | NIH | 4/15/2024 | $21,411 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA225439 | Tribally Engaged Approaches to Lung Screening (TEALS) | 000 | 5 | NIH | 11/15/2023 | $385,352 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P20GM134973 | Oklahoma Center for Microbial Pathogenesis and Immunity | 001 | 5 | NIH | 1/25/2024 | $1,934,669 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P20GM134973 | Oklahoma Center for Microbial Pathogenesis and Immunity | 002 | 5 | NIH | 4/9/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R37AI037657 | Pore Formation by Cholesterol Dependent Cytolysins | 000 | 28 | NIH | 3/6/2024 | $427,638 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI119048 | Differential Effects of TcdB1 and TcdB2 in C. difficile disease | 000 | 10 | NIH | 1/11/2024 | $389,070 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P20GM103447 | Administrative Supplement to the Existing Oklahoma INBRE Award | 001 | 24 | NIH | 3/28/2024 | $4,005,239 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F99AG079813 | Reversing age-related epigenetic changes and characterizing microglia heterogeneity in obesity and aging | 000 | 2 | NIH | 10/25/2023 | $36,513 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21CA271218 | Non-invasive assessment of graft vs host disease using optoacoustic imaging | 000 | 2 | NIH | 12/21/2023 | $183,026 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK134316 | Novel Roles of Cullin-RING E3 Ligases in Liver Pathophysiology | 000 | 2 | NIH | 2/2/2024 | $353,583 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R25GM144169 | Post-Baccalaureate Research and Education Program (PREP) for Oklahoma | 001 | 2 | NIH | 2/22/2024 | $242,790 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK133207 | ROCK, tight junctions and prematurity in the pathogenesis of necrotizing enterocolitis and neonatal sepsis. | 000 | 2 | NIH | 1/19/2024 | $434,659 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21CA280049 | Investigating the impact of local land use and zoning policies on equitably reducing tobacco retailer availability | 000 | 2 | NIH | 4/9/2024 | $204,412 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21AI175595 | Functional and transcriptome analyses of protein kinases in Candida glabrata antifungal drug resistance | 001 | 2 | NIH | 2/14/2024 | $195,750 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01DA055073 | Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach | 000 | 2 | NIH | 2/8/2024 | $183,165 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK129656 | Understanding the metabolic pathology of pediatric obesity and NAFLD | 000 | 3 | NIH | 1/19/2024 | $511,035 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AT012165 | The Impact of Structural Racism and Discrimination (SRD) on Mechanisms of the Native American Pain Disparity | 000 | 3 | NIH | 3/22/2024 | $494,567 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG070086 | The Effects of Diet and Exercise Interventions in Peripheral Artery Disease | 001 | 3 | NIH | 1/10/2024 | $394,643 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA053342 | Diversity Supplement to Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms | 001 | 3 | NIH | 3/22/2024 | $49,337 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA053342 | Diversity Supplement to Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms | 000 | 3 | NIH | 3/15/2024 | $500,450 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL161008 | Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillation | 000 | 3 | NIH | 12/15/2023 | $379,983 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK131064 | Sulfur Amino Acid Metabolism and Regulation of Hepatic Metabolic Flexibility | 000 | 3 | NIH | 12/5/2023 | $370,911 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA260449 | Exploiting gold nanoparticle as a probe to identify therapeutic targets | 000 | 3 | NIH | 12/1/2023 | $59,566 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31DK130605 | WNT signaling in Autosomal Dominant Polycystic Kidney Disease | 000 | 3 | NIH | 1/17/2024 | $35,757 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK128848 | Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment | 001 | 4 | NIH | 3/11/2024 | $411,806 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01MD015295 | HealthyCells: A Culturally-Tailored Smoking Cessation Smartphone Intervention for African Americans with Adjunctive Treatment for Sedentary Behavior | 000 | 4 | NIH | 1/29/2024 | $121,243 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA251451 | Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults | 000 | 4 | NIH | 3/18/2024 | $546,169 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI154274 | Cellular Mechanism of Oxysterol-Binding Protein (OSBP) in Viral Proliferation: A Chemical Biology Approach | 001 | 4 | NIH | 3/21/2024 | $17,416 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI154274 | Cellular Mechanism of Oxysterol-Binding Protein (OSBP) in Viral Proliferation: A Chemical Biology Approach | 000 | 4 | NIH | 3/20/2024 | $397,764 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK126705 | Ciliary Disassembly, a modifier of Autosomal Dominant Polycystic Kidney Disease | 000 | 4 | NIH | 1/10/2024 | $320,676 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA255840 | Chemotherapy-induced vascular cognitive impairment: role of endothelial senescence | 000 | 4 | NIH | 12/8/2023 | $298,519 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA253391 | Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system | 000 | 4 | NIH | 12/21/2023 | $328,189 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL152205 | A cardiac Wingless-Snail-Tep2 axis directs normal lipid homeostasis and protects against diet-induced obesity | 000 | 5 | NIH | 3/11/2024 | $362,500 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA287044 | Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub | 000 | 1 | NIH | 2/14/2024 | $805,511 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R00GM141267 | Identification of novel osmosensing receptors in C. elegans | 000 | 3 | NIH | 2/23/2024 | $248,999 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31DK137568 | Targeting kidney resident macrophage niche filling to slow cystic kidney disease | 000 | 1 | NIH | 3/27/2024 | $36,159 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21EY035725 | Targeting Innate Inflammation Pathways to Treat Ocular Infections | 000 | 1 | NIH | 12/15/2023 | $181,250 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK139443 | Evaluating PQQ for preventing maternal obesity-induced fetal programming of juvenile NAFLD in Papio anubis | 000 | 1 | NIH | 3/14/2024 | $621,994 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31DE033289 | Understanding the role of PDGFRb signaling in Penttinen syndrome craniofacial development | 000 | 1 | NIH | 1/12/2024 | $35,738 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL169530 | Mechanism of F-18-fluorodeoxyglucarate accrual in myocardial injury | 000 | 1 | NIH | 3/29/2024 | $362,500 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R03CA289562 | Role of JMJD4 in Breast Cancer | 000 | 1 | NIH | 2/23/2024 | $72,500 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31AI179208 | Toxin B receptor mediated events in Clostridioides difficile disease | 001 | 1 | NIH | 1/30/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31AI179208 | Toxin B receptor mediated events in Clostridioides difficile disease | 000 | 1 | NIH | 1/30/2024 | $35,294 |
|
